James Shin
Stock Analyst at Deutsche Bank
(0.97)
# 3,581
Out of 4,711 analysts
18
Total ratings
25%
Success rate
-5.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly | Maintains: Buy | $1,025 → $1,015 | $767.76 | +32.20% | 4 | Nov 4, 2024 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $263.38 | +15.80% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $68.84 | -12.84% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $57.33 | -21.51% | 2 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $34.08 | +76.06% | 1 | May 23, 2024 | |
| GILD Gilead Sciences | Initiates: Hold | $75 | $92.57 | -18.98% | 1 | Nov 9, 2023 | |
| ABBV AbbVie | Initiates: Hold | $150 | $175.58 | -14.57% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $701.85 | +13.98% | 1 | Nov 9, 2023 | |
| MRK Merck & Co. | Initiates: Buy | $115 | $98.05 | +17.29% | 1 | Nov 9, 2023 | |
| AUTL Autolus Therapeutics | Initiates: Buy | $10 | $2.29 | +336.68% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.88 | +538.30% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $1.19 | +5,782.35% | 1 | Dec 12, 2022 |
Eli Lilly
Nov 4, 2024
Maintains: Buy
Price Target: $1,025 → $1,015
Current: $767.76
Upside: +32.20%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $263.38
Upside: +15.80%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $68.84
Upside: -12.84%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $57.33
Upside: -21.51%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $34.08
Upside: +76.06%
Gilead Sciences
Nov 9, 2023
Initiates: Hold
Price Target: $75
Current: $92.57
Upside: -18.98%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $175.58
Upside: -14.57%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $701.85
Upside: +13.98%
Merck & Co.
Nov 9, 2023
Initiates: Buy
Price Target: $115
Current: $98.05
Upside: +17.29%
Autolus Therapeutics
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $2.29
Upside: +336.68%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $1.88
Upside: +538.30%
Dec 12, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $1.19
Upside: +5,782.35%